Brief: Myriad Genetics Inc - On Oct 10, 2023, Agreed On New Long-Term Agreement With UnitedHealthcare
11/10/2023 14:07
Oct 11 (Reuters) - Myriad Genetics Inc MYGN.O :
* MYRIAD GENETICS INC - ON OCT 10, 2023, AGREED ON NEW
LONG-TERM
AGREEMENT WITH UNITEDHEALTHCARE
* MYRIAD GENETICS INC - CONTRACT AMENDMENT IS EFFECTIVE
JANUARY 1,
2024 AND RUNS THROUGH DECEMBER 31, 2027
* MYRIAD GENETICS INC:AGREEMENT INCLUDES PRICING FOR
PRODUCTS
INCLUDING BUT NOT LIMITED TO MYRISK, MYCHOICE CDX, BRACANALYSIS
CDX, FORESIGHT AND OTHERS
Source text for Eikon: ID:
Further company coverage: MYGN.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple